NEW YORK, 27 SEPT 2024: The US Food and Drug Administration said Tuesday that it plans to reclassify several types of qualitative and quantitative hepatitis B virus (HBV) tests as moderate risk Class II devices from their current classification as high-risk Class III devices.

......
View Details

Related News

• PIL questioning quality of Anti-Rabies Vaccine disposed of by SC (22-01-2025)

---

• NCB seizes drugs worth more than 14 lakhs in Jaipur, One arrested (21-01-2025)

---

• Trump withdraws US from WHO (21-01-2025)

---

• Telangana Officials Raid Illegal De-Addiction Center in Hanumakonda (21-01-2025)

---

• Major pharmacy benefit managers found by US FTC to have inflated drug prices for a $7.3 billion gain (21-01-2025)

---

• Agra: Child given expired vaccine, doctor said- a mistake happened (21-01-2025)

---

• Police Seize Nearly 1,300 Bottles of Codeine Cough Syrup in Abandoned Vehicle (21-01-2025)

---

• Vaccine sector does not require incentives or breaks but needs relief from rigid price controls: Adar Poonawalla (21-01-2025)

---

• CSIR-IIIM Hosts Groundbreaking Workshop on Herbal Medicine Production (21-01-2025)

---

• 530 Sedative Pills seized from Nalagarh resident (21-01-2025)

---